Expertise in
8
conditions

Ulrich P. Knigge

Rigshospitalet
Copenhagen, DK 
Expertise in
8
conditions
Rigshospitalet
Copenhagen, DK 

Overview

Ulrich Knigge practices practicing medicine in Copenhagen, Denmark.

Mr. Knigge is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Appendix Cancer, Appendectomy, and Hepato-Pancreato-Biliary Surgery.

He is actively involved in clinical research, co-authoring 117 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Rigshospitalet
Copenhagen, Denmark
Other Locations
Kobenhavn O, 2100, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Open Label Study to Compare the Efficacy and Safety of Everolimus Followed by Chemotherapy With Streptozotocin- Fluorouracilo (STZ-5FU) Upon Progression or the Reverse Sequence, in Advanced Progressive Pancreatic NETs (pNETs)
Randomized Open Label Study to Compare the Efficacy and Safety of Everolimus Followed by Chemotherapy With Streptozotocin- Fluorouracilo (STZ-5FU) Upon Progression or the Reverse Sequence, in Advanced Progressive Pancreatic NETs (pNETs)
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug
Study Drug: STZ-5FU
Study Phase: Phase 3
A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
Enrollment Status: Terminated
Publish Date: July 06, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

117 Total Publications

Response to "Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids".
Response to "Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids".
Journal: Journal of neuroendocrinology
Published: June 09, 2026

Frequently Asked Questions about Ulrich P. Knigge

Is Ulrich P. Knigge a top-rated expert for Neuroendocrine Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Ulrich P. Knigge is classified as an Elite expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ulrich P. Knigge participate in research or clinical trials?

Yes. Ulrich P. Knigge has published 117 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Ulrich P. Knigge's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Knigge's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile